U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H37N5O7
Molecular Weight 447.5264
Optical Activity UNSPECIFIED
Defined Stereocenters 11 / 11
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PENTISOMICIN

SMILES

[H][C@]3(O[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O[C@@]2([H])OC[C@](C)(O)[C@H](NC)[C@H]2O)[C@@H]1O)OC(CN)=CC[C@H]3N

InChI

InChIKey=URWAJWIAIPFPJE-VHLNBGGKSA-N
InChI=1S/C19H37N5O7/c1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17/h3,9-18,24-27H,4-7,20-23H2,1-2H3/t9-,10+,11-,12-,13-,14-,15+,16-,17-,18-,19+/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3839236 | https://www.ncbi.nlm.nih.gov/pubmed/4073862 | https://www.ncbi.nlm.nih.gov/pubmed/3571044

Pentisomicin (Sch 21420) is semisynthetic aminoglycosides with marked antibacterial activity. Like many new aminoglycosides prepared by chemical modification or mutational biosynthesis, Pentisomicin was designed either to enhance potency of the parent compound and/or resist enzymatic inactivation. The activity of Pentisomicin was comparable to gentamicin, sisomicin, netilmicin, and tobramycin but greater than amikacin or kanamycin against S. aureus and most genera of Enterobacteriaceae.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Human pharmacology of 5-epi-sisomicin (Sch 22591) following intramuscular administration.
1987 Feb
Patents

Patents

Sample Use Guides

5-epi-sisomicin (Pentisomicin) was given as a single 1 mg/kg intramuscular injection to six adult male volunteers.
Route of Administration: Intramuscular
In Vitro Use Guide
Agar dilution susceptibility tests were performed with N. gonorrhoeae. Serial twofold agar dilution tests were performed with GC agar base (BBL) plus 1% Kellogg defined supplement. A standardized suspension of cells was prepared from an overnight culture on chocolate agar so that inoculation of each test plate with 0.01 ml (calibrated loop) yielded ca. 10^4 CFU/cm2. The MIC was defined as the lowest concentration of Pentisomicin preventing all growth after 24 h of incubation at 37C in 10% C02 in air.
Name Type Language
PENTISOMICIN
INN   USAN  
INN   USAN  
Official Name English
pentisomicin [INN]
Common Name English
SCH-22591
Code English
PENTISOMICIN [USAN]
Common Name English
SCH 22591
Code English
Code System Code Type Description
PUBCHEM
65453
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
INN
4654
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
CAS
55870-64-9
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105403
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
SMS_ID
100000082515
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
MESH
C015852
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
FDA UNII
L5BS6WSR0E
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
EPA CompTox
DTXSID7046887
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
EVMPD
SUB09696MIG
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY
NCI_THESAURUS
C175840
Created by admin on Sat Dec 16 17:52:59 GMT 2023 , Edited by admin on Sat Dec 16 17:52:59 GMT 2023
PRIMARY